Educational Intervention by Clinical Pharmacist to Improve Cancer Patients Views on Stopping Non-Cancer Medications in Palliative Care

What this Trial Is About

Cancer patients in palliative care often take many medications, which can increase the risk of drug-related problems, including adverse reactions and hospitalizations. This research studies cancer patients attitudes toward stopping non-cancer medications, a process called deprescribing, and examines how well patients understand medical information. The study also evaluates whether an educational intervention by a clinical pharmacist can improve patient engagement and knowledge about their medications. Participants will first complete two validated questionnaires in Romanian one assessing attitudes toward deprescribing rPATD, and another measuring health literacy HLS-EU-Q16. After this, they will receive educational materials including a brochure and a video explaining deprescribing, medication effectiveness, adverse reactions, and the patients role in treatment decisions. Participants will complete the rPATD questionnaire again at their next cancer treatment cycle, which occurs after 14, 21, or 28 days. Throughout the study, participants will answer questionnaires about their views on deprescribing and their understanding of health information. Researchers will measure changes in attitudes toward stopping medications before and after the educational intervention and assess health literacy at enrollment. The study lasts from enrollment until the next cancer treatment cycle, with timing depending on the participants treatment schedule.

Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Pharmacist